<DOC>
	<DOCNO>NCT01630044</DOCNO>
	<brief_summary>This prospective , non-randomized unblinded study design generate preliminary data assess effect new portable non-invasive brainstem stimulator treat migraine headache patient episodic migraine headache .</brief_summary>
	<brief_title>Neurostimulation Device Treatment Migraine Headache</brief_title>
	<detailed_description>This study single-center , unblinded , non-randomized clinical trial adjunctive prophylactic treatment episodic migraine headache use neuromodulation device develop Scion NeuroStim , LLC ( SNS ) . The investigational use device episodic migraine headache review FDA classify NSR ( non-significant risk ) .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>On Monthly basis , least four , total fourteen Headache Days ( Pain Score one ten ) four nine Migraine Headache Days ( Pain Score five ten ) . NOTE : For clarification , occurrence Headaches count take account , make adjustment , medication subject take ; A history responsiveness ( incomplete ) least one maximum two prophylactic pharmaceutical therapy ( utilized concurrently ) ; The investigator must confidence patient 's ability reliably complete return Daily Headache Diary . Subject must least 18 year age . Individuals pregnant , history cardiovascular disease , work night shift vestibular migraine , menstrual migraine , posttraumatic migraine , history unstable mood disorder unstable anxiety , moderate great hearing loss history traumatic brain injury exclude Study . A history within last six month tobacco use , narcotic barbiturate use experience one analgesic rebound headache .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>